Rheumatoid Arthritis News

    Skip to content
    • Home
    • Treatments
      • Tofacitinib (Xeljanz)
    • Experimental Treatments
      • Piclidenoson
      • Kevzara (Sarilumab)
      • Baricitinib (Olumiant)
    • About Us
    • Contact Us
    •
      June 12, 2017August 24, 2022

      Diplomat Pharmacy Begins Dispensing Kevzara to Treat Rheumatoid Arthritis

      Diplomat Pharmacy has begun filling prescriptions for Kevzara (sarilumab) for patients with moderate to severe rheumatoid arthritis (RA). The announcement comes after the U.S. Food and Drug ... Read more
    • June 7, 2017June 7, 2017

      Filgotinib Improves RA Patient Outcomes When Methotrexate Is Inadequate, Study Suggests

      Active rheumatoid arthritis (RA) patients whose response to methotrexate (MTX) therapy was insufficient showed improvement when MTX was combined with filgotinib, an investigational JAK–1 inhibitor, according ... Read more
    • June 5, 2017June 5, 2017

      EMA Accepts Humira and Remicade Biosimilars for Regulatory Review

      The European Medicines Agency (EMA) has accepted a marketing authorization application from generic pharmaceuticals developer Sandoz for the review of biosimilars for AbbVie’s Humira (adalimumab) and Janssen’s Remicade (infliximab), ... Read more
    • June 2, 2017June 2, 2017

      DMARDs Triple Therapy Provides Better Cost-Effective First Line Strategy for RA, Study Finds

      Results of a recent study showed that biological therapy regimens, such as Enbrel (etanercept), Humira (adalimumab), ‎Remicade (infliximab), ‎Simponi (golimumab), or ‎Cimzia (certolizumab), are less cost-effective ... Read more
    • May 23, 2017May 23, 2017

      Kevzara Approved by FDA for Treatment of RA in Adults Who Don’t Respond to DMARDs

      Kevzara (sarilumab) was approved by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with moderate to severely active rheumatoid arthritis ... Read more
    Methotrexate-Refractory Rheumatoid Arthritis Patients See Better Results with Combo Drug Treatment, According to Analysis
    June 6, 2016June 7, 2016

    Methotrexate-Refractory Rheumatoid Arthritis Patients See Better Results with Combo Drug Treatment, According to Analysis

    News
    Korean researchers compared the efficacy of a number of biological agents in rheumatoid arthritis (RA) patients refractory to methotrexate (MTX), and found that certolizumab and golimumab, two monoclonal antibodies that ... Read more
    #EULAR2016 – AbbVie to Show New Data on RA Therapy Humira, Present Research on Drug Candidate ABT-494
    June 6, 2016June 6, 2016

    #EULAR2016 – AbbVie to Show New Data on RA Therapy Humira, Present Research on Drug Candidate ABT-494

    News
    AbbVie has announced that key data regarding Humira (adalimumab) will be presented at the Annual European Congress of Rheumatology (EULAR 2016) June 8-11 in London, England. The data includes investigational research along with ... Read more
    New Protein That Regulates T Cell Responses May Bring New Therapies for RA
    May 27, 2016May 27, 2016

    New Protein That Regulates T Cell Responses May Bring New Therapies for RA

    News
    Researchers at the Sanford Burnham Prebys Medical Discovery Institute (SBP) and colleagues have identified a protein that regulates T cell responses, which might explain why the immune system sometimes fails ... Read more
    Rheumatoid Arthritis Management Guidelines Stressed
    May 23, 2016May 23, 2016

    Rheumatoid Arthritis Management Guidelines Stressed

    News
    During the Congress of Clinical Rheumatology Annual Meeting, Dr. Daniel Aletaha, associate professor of medicine at the Medical University of Vienna in Austria, discussed three principals and a list of recommendations for rheumatologists ... Read more
    Rheumatoid Arthritis Treatments Can Lower Cardiovascular Disease Risk, Researcher Says
    May 20, 2016May 20, 2016

    Rheumatoid Arthritis Treatments Can Lower Cardiovascular Disease Risk, Researcher Says

    News
    Rheumatoid arthritis (RA) therapies may reduce cardiovascular disease risk in RA patients, according to a research presentation by Dr. Joan Bathon, chief of the Division of Rheumatology at Columbia University College of ... Read more
    Pfizer’s Newest RA Survey Finds a Disconnect in Doctor-Patient Communication
    May 18, 2016May 18, 2016

    Pfizer’s Newest RA Survey Finds a Disconnect in Doctor-Patient Communication

    News
    Pfizer recently reported the results from the second phase of its global survey — RA NarRAtive — involving more than 1,700 rheumatologists in 15 countries. The rheumatoid arthritis (RA) surveys, an ongoing initiative sponsored by ... Read more
    myVectra, a Web Portal and Mobile App, Helps RA Patients Track Disease Changes
    May 13, 2016May 13, 2016

    myVectra, a Web Portal and Mobile App, Helps RA Patients Track Disease Changes

    News
    Myriad Genetics, Inc., a personalized medicine subsidiary of Crescendo Bioscience, has launched a new web portal called myVectra for people with rheumatoid arthritis (RA). myVectra users can easily access their Vectra DA test results ... Read more
    RA Patients in UK Seen to Largely Ignore Flu and Pneumonia Vaccine Guidelines
    May 11, 2016May 11, 2016

    RA Patients in UK Seen to Largely Ignore Flu and Pneumonia Vaccine Guidelines

    News
    University of Manchester researchers investigating how closely rheumatoid arthritis (RA) patients adhere to influenza and pneumococcal vaccination guidelines, found only suboptimal compliance — a factor that greatly contributes to their high risk of contracting such infections. The ... Read more
    Tobacco Smoke Not Seen in Small Study to Worsen Rheumatoid Arthritis
    May 10, 2016May 11, 2016

    Tobacco Smoke Not Seen in Small Study to Worsen Rheumatoid Arthritis

    News, rheumatoid arthritis
    Researchers in Ankara, Turkey, found no connection between cigarette smoking — either active or passive — and disease activity in people with rheumatoid arthritis (RA), according to the study “Effect of Exposure ... Read more
    Salt-Inducible Kinases, a Type of Enzyme, Seen as Inflammatory Target in Early Study
    May 6, 2016May 6, 2016

    Salt-Inducible Kinases, a Type of Enzyme, Seen as Inflammatory Target in Early Study

    News, rheumatoid arthritis
    Researchers found that inhibition of certain type of enzymes, the salt-inducible kinases, significantly reduces the production of inflammatory molecules and promotes an immune cell phenotype characterized by anti-inflammatory agents. The findings ... Read more

    Posts navigation

    Older posts
    Newer posts

    Never miss another RA update.

    * indicates required
    Bionews, Inc.
    3 W Garden St
Suite 700
Pensacola, FL 32502
Email: [email protected]
Phone: +1-800-936-1363

    Recent Posts

    • Diplomat selling Kevzara

      Diplomat Pharmacy Begins Dispensing Kevzara to Treat Rheumatoid Arthritis

      June 12, 2017

    • Filgotinib Improves RA Patient Outcomes When Methotrexate Is Inadequate, Study Suggests

      June 7, 2017

    • Truxima, a biosimilar of rituximab

      EMA Accepts Humira and Remicade Biosimilars for Regulatory Review

      June 5, 2017

    • triple therapy

      DMARDs Triple Therapy Provides Better Cost-Effective First Line Strategy for RA, Study Finds

      June 2, 2017

    • About Us
    • Contact Us
    • Terms of Service
    • Privacy Policy

    Disclaimer:

    Rheumatoid Arthritis News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
    Copyright © 2013-2025 All rights reserved.